Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed and Cisplatin Followed by Surgery and Radiation for Mesothelioma
NCT00227630Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of pemetrexed, cisplatin in malignant pleural mesothelioma (MPM), sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 2005; status: completed.
02
Drugs
pemetrexedcisplatin
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00227630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227630.